Atriva Therapeutics Overview

  • Founded
  • 2015
Founded
  • Status
  • Private
  • Employees
  • 15
Employees
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $13.4M
Latest Deal Amount
  • Investors
  • 8

Atriva Therapeutics General Information

Description

Developer of antiviral therapies intended to treat diverse respiratory viral infections. The company's developed therapies target viral replication in influenza and modulate the body's immune response and focus on acute viral infections such as influenza and other respiratory syncytial viruses, enabling patients to get access to efficacious therapeutics against numerous viral infections.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Biotechnology
Primary Office
  • Eisenbahnstraße 1
  • 72072 Tübingen
  • Germany
+49 0701 0000 0000

Atriva Therapeutics Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Atriva Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Grant 21-Apr-2021 $13.4M 000.00 Completed Generating Revenue
5. Debt - General 20-Oct-2020 000.00 000.00 Completed Pre-Clinical Trials
4. Later Stage VC 11-Aug-2020 0000 0000 Completed Pre-Clinical Trials
3. Grant 17-Jul-2019 00000 000 Completed Pre-Clinical Trials
2. Early Stage VC (Series A) 01-Jan-2019 $3.42M $7M Completed Pre-Clinical Trials
1. Seed Round 21-Sep-2017 $3.58M $3.58M 000.00 Completed Pre-Clinical Trials
To view Atriva Therapeutics’s complete valuation and funding history, request access »

Atriva Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of antiviral therapies intended to treat diverse respiratory viral infections. The company's developed therapi
Drug Discovery
Tübingen, Germany
15 As of 2021
000.00
0000000000 000.00

0000000

g elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam,
0000 000000000
Diepenbeek, Belgium
0 As of 0000
000.00
000000 - 000 000.00

00000000

in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occa
0000 000000000
Rockville, MD
0 As of 0000
000.00
0000000000 0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Atriva Therapeutics Competitors (54)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Apitope Venture Capital-Backed Diepenbeek, Belgium 0 000.00 000000 - 000 000.00
000000000 00000000 Venture Capital-Backed Rockville, MD 0 000.00 0000000000 0 000.00
0000 00000000000 Venture Capital-Backed Cambridge, MA 00 00000 00000000000 00000
0000000 0000000000 Venture Capital-Backed Niel, Belgium 00 000.00 00000000000 000.00
0000000 0000000000 Formerly VC-backed Boston, MA 0 00000 000000000 00000
You’re viewing 5 of 54 competitors. Get the full list »

Atriva Therapeutics Executive Team (11)

Name Title Board Seat Contact Info
Rainer Lichtenberger Ph.D Co-Founder, Chief Executive Officer & President
Olaf Althaus Chief Financial Officer
Christian Wallasch Ph.D Chief Operating Officer
Oliver Planz Ph.D Chief Scientific Officer
Stephan Stenglein Chief Medical Officer
You’re viewing 5 of 11 executive team members. Get the full list »

Atriva Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Atriva Therapeutics Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Bundesministerium für Bildung und Forschung Government 000 0000 000000 0
Integrated Biobank of Luxembourg Government 000 0000 000000 0
Locapes Investment Fund Venture Capital Minority 000 0000 000000 0
Meneldor Venture Capital Minority 000 0000 000000 0
B.I.F. Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »